Author:
Jangid Ashok Kumar,Jain Poonam,Pooja Deep,Kulhari Hitesh
Reference141 articles.
1. Accomasso, L., Cristallini, C., & Giachino, C. (2018). Risk assessment and risk minimization in nanomedicine: A need for predictive, alternative and 3Rs strategies. Frontiers in Pharmacology, 9, 228.
2. Afzal, M., Ameeduzzafar, Alharbi, K. S., Alruwaili, N. K., Al-Abassi, F. A., Al-Malki, A. A. L., et al. (2019). Nanomedicine in treatment of breast cancer—a challenge to conventional therapy. Seminars in Cancer Biology, 1, 31870940.
3. Ahmad, U., Ahmad, Z., Khan, A. A., Akhtar, J., Singh, S. P., & Ahmad, F. J. (2018). Strategies in development and delivery of nanotechnology based cosmetic products. Drug Research, 68(10), 545–552.
4. Albertazzi, L., Gherardini, L., Brondi, M., Sulis Sato, S., Bifone, A., Pizzorusso, T., et al. (2013). In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry. Molecular Pharmaceutics, 10(1), 249–260.
5. Avasthi, A., Caro, C., Pozo-Torres, E., Leal, M. P., & García-Martín, M. L. (2020). Magnetic nanoparticles as MRI contrast agents. Topics in Current Chemistry, 378(3), 40.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanomaterials in Biomedicine;Biomedical Materials for Multi-functional Applications;2024